The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...

The enforcement action is part of an escalating conflict between the FTC and the three pharmacy benefit managers that ...

The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...

The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...

9月10日晚间，双成药业发布重组预案，拟通过发行股份及支付现金的方式购买宁波奥拉半导体股份有限公司100%股份。双成药业完成收购后，发展重心也将从医药制造业转移到半导体行业中的模拟芯片及数模混合芯片的研发、设计和销售业务，并在未来择机剥离医药类相关资 ...